Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.3 HKD 0.3% Market Closed
Market Cap: 60.5B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

Sino Biopharmaceutical Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sino Biopharmaceutical Ltd
Capital Expenditures Peer Comparison

Comparables:
G
512
U
3933
C
570
C
3320
H
13

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biopharmaceutical Ltd
HKEX:1177
Capital Expenditures
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Capital Expenditures
-HK$497.7m
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
U
United Laboratories International Holdings Ltd
HKEX:3933
Capital Expenditures
-ÂĄ1.4B
CAGR 3-Years
-26%
CAGR 5-Years
-20%
CAGR 10-Years
-5%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Capital Expenditures
-ÂĄ488.6m
CAGR 3-Years
25%
CAGR 5-Years
17%
CAGR 10-Years
-12%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Capital Expenditures
-HK$3.1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Capital Expenditures
-$18.4m
CAGR 3-Years
10%
CAGR 5-Years
-18%
CAGR 10-Years
-16%

See Also

What is Sino Biopharmaceutical Ltd's Capital Expenditures?
Capital Expenditures
-1.1B CNY

Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Capital Expenditures amounts to -1.1B CNY.

What is Sino Biopharmaceutical Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
22%

Over the last year, the Capital Expenditures growth was 22%.

Back to Top